These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34537250)

  • 1. Comparative responsiveness of cutaneous lupus erythematosus patients to methotrexate and mycophenolate mofetil: A cohort study.
    Keyes E; Jobanputra A; Feng R; Grinnell M; Vazquez T; Diaz D; Werth VP
    J Am Acad Dermatol; 2022 Aug; 87(2):447-448. PubMed ID: 34537250
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of cutaneous lupus.
    Chang AY; Werth VP
    Curr Rheumatol Rep; 2011 Aug; 13(4):300-7. PubMed ID: 21503694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolic acid exposure and complement fraction C3 influence inosine 5'-monophosphate dehydrogenase activity in systemic lupus erythematosus.
    Mino Y; Naito T; Shimoyama K; Ogawa N; Kawakami J
    Ann Clin Biochem; 2017 Jul; 54(4):490-494. PubMed ID: 27538768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of mycophenolate mofetil in antimalarial-resistant cutaneous lupus erythematosus.
    Gammon B; Hansen C; Costner MI
    J Am Acad Dermatol; 2011 Oct; 65(4):717-721.e2. PubMed ID: 21641078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).
    Kuhn A; Aberer E; Bata-Csörgő Z; Caproni M; Dreher A; Frances C; Gläser R; Klötgen HW; Landmann A; Marinovic B; Nyberg F; Olteanu R; Ranki A; Szepietowski JC; Volc-Platzer B
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):389-404. PubMed ID: 27859683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil and skin diseases.
    Hartmann M; Enk A
    Lupus; 2005; 14 Suppl 1():s58-63. PubMed ID: 15803935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous lupus erythematosus: update of therapeutic options part II.
    Kuhn A; Ruland V; Bonsmann G
    J Am Acad Dermatol; 2011 Dec; 65(6):e195-213. PubMed ID: 20800319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil and systemic lupus erythematosus: an overview.
    Pisoni CN; Karim Y; Cuadrado MJ
    Lupus; 2005; 14 Suppl 1():s9-11. PubMed ID: 15803925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetil.
    Schanz S; Ulmer A; Rassner G; Fierlbeck G
    Br J Dermatol; 2002 Jul; 147(1):174-8. PubMed ID: 12100205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate in systemic lupus erythematosus.
    Wenzel J
    Lupus; 2005; 14(7):569. PubMed ID: 16130518
    [No Abstract]   [Full Text] [Related]  

  • 11. Chilblain lupus erythematosus treated successfully with mycophenolate mofetil.
    Gouillon L; Debarbieux S; Berruyer M; Fabien N; Lega JC; Thomas L
    Int J Dermatol; 2017 Aug; 56(8):e158-e159. PubMed ID: 28345755
    [No Abstract]   [Full Text] [Related]  

  • 12. Coexisting subacute and systemic lupus erythematosus after terbinafine administration: successful treatment with mycophenolate mofetil.
    Cetkovská P; Pizinger K
    Int J Dermatol; 2006 Mar; 45(3):320-2. PubMed ID: 16533240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous Lupus: A Brief Review of Old and New Medical Therapeutic Options.
    Nutan F; Ortega-Loayza AG
    J Investig Dermatol Symp Proc; 2017 Oct; 18(2):S64-S68. PubMed ID: 28941497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chilblain lupus erythematosus Hutchinson: successful treatment with mycophenolate mofetil.
    Boehm I; Bieber T
    Arch Dermatol; 2001 Feb; 137(2):235-6. PubMed ID: 11176709
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of severe refractory lupus hepatitis with mycophenolate mofetil.
    Tagawa Y; Saito T; Takada K; Kawahata K; Kohsaka H
    Lupus; 2016 Apr; 25(5):543-6. PubMed ID: 26762472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents.
    Karim MY; Alba P; Cuadrado MJ; Abbs IC; D'Cruz DP; Khamashta MA; Hughes GR
    Rheumatology (Oxford); 2002 Aug; 41(8):876-82. PubMed ID: 12154204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil: a magic bullet for lupus?
    McCune WJ; Riskalla MM
    J Rheumatol; 2005 Jun; 32(6):967-70. PubMed ID: 15940751
    [No Abstract]   [Full Text] [Related]  

  • 18. Pseudo-Pelger-Huët anomaly in a 58-year-old woman treated with mycophenolate mofetil for flare of systemic lupus erythematosus.
    Zhao Y; Rehder C; Wang E
    Int J Lab Hematol; 2021 Feb; 43(1):3-4. PubMed ID: 33206453
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of pulmonary hemorrhage in childhood systemic lupus erythematosus with mycophenolate mofetil.
    Samad AS; Lindsley CB
    South Med J; 2003 Jul; 96(7):705-7. PubMed ID: 12940327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of resistant discoid lupus erythematosus of the palms and soles with mycophenolate mofetil.
    Goyal S; Nousari HC
    J Am Acad Dermatol; 2001 Jul; 45(1):142-4. PubMed ID: 11423853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.